FRANK ROCKHOLD, Session III Co-Chair

Senior Vice President

Global Clinical Safety and Pharmacovigilance

GlaxoSmithKline Pharmaceuticals Research and Development

LYNN HUDSON, Session III Co-Chair

Chief Science Officer and Executive Director

Coalition Against Major Diseases, Critical Path Institute

ROBERT HARRINGTON, Session IV Chair

Arthur L. Bloomfield Professor of Medicine

Chair, Department of Medicine

Stanford University

12:00 p.m.

Closing Discussion with Session Chairs, Panelists, and Audience Led by Workshop Chair

JOSEPHINE BRIGGS

Director, National Center for Complementary and

Alternative Medicine

Director, National Center for Advancing Translation

Sciences, Division of Clinical Innovation

National Institutes of Health

MICHAEL ROSENBLATT

Executive Vice President and Chief Medical Officer

Merck & Co., Inc.

JAY “MARTY” TENENBAUM

Founder and Chair

Cancer Commons

JANET WOODCOCK

Director, Center for Drug Evaluation and Research

U.S. Food and Drug Administration

12:45 p.m.

ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement